Quinolone-mediated bacterial death.
作者信息
Drlica Karl, Malik Muhammad, Kerns Robert J, Zhao Xilin
机构信息
Public Health Research Institute, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, 225 Warren St., Newark, NJ 07103, USA.
出版信息
Antimicrob Agents Chemother. 2008 Feb;52(2):385-92. doi: 10.1128/AAC.01617-06. Epub 2007 Aug 27.
Abstract
摘要
相似文献
1
Quinolone-mediated bacterial death.
Antimicrob Agents Chemother. 2008 Feb;52(2):385-92. doi: 10.1128/AAC.01617-06. Epub 2007 Aug 27.
2
Recent advances in bacterial topoisomerase inhibitors.
Curr Opin Pharmacol. 2008 Oct;8(5):574-81. doi: 10.1016/j.coph.2008.04.009. Epub 2008 Jun 12.
3
Antibacterial action of quinolones: from target to network.
Eur J Med Chem. 2013 Aug;66:555-62. doi: 10.1016/j.ejmech.2013.01.057. Epub 2013 Mar 4.
4
[The molecular physiological and genetic mechanisms underlying the superb efficacy of quinolones].
Yao Xue Xue Bao. 2012 Aug;47(8):969-77.
5
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.
Chem Biol. 2010 May 28;17(5):421-33. doi: 10.1016/j.chembiol.2010.04.012.
6
Topoisomerase inhibition, nucleolytic and electrolytic contribution on DNA binding activity exerted by biological active analogue of coordination compounds.
Appl Biochem Biotechnol. 2012 Apr;166(8):1949-68. doi: 10.1007/s12010-012-9623-x. Epub 2012 Mar 7.
7
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.
Molecules. 2020 Dec 1;25(23):5662. doi: 10.3390/molecules25235662.
8
Novel quinolone derivatives as potent antibacterials.
Bioorg Med Chem Lett. 1998 Mar 3;8(5):525-8. doi: 10.1016/s0960-894x(98)00063-8.
9
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
J Antimicrob Chemother. 2003 May;51(5):1109-17. doi: 10.1093/jac/dkg222. Epub 2003 Apr 14.
10
Mechanism of action of and resistance to quinolones.
Microb Biotechnol. 2009 Jan;2(1):40-61. doi: 10.1111/j.1751-7915.2008.00063.x. Epub 2008 Oct 13.
引用本文的文献
1
Conservation and divergence of ciprofloxacin persister survival mechanisms between Pseudomonas aeruginosa and Escherichia coli.
PLoS Genet. 2025 Sep 2;21(9):e1011840. doi: 10.1371/journal.pgen.1011840. eCollection 2025 Sep.
2
Quinolone Resistance and Zoonotic Potential of from Domestic Animals in Brazil.
Antibiotics (Basel). 2025 Aug 20;14(8):843. doi: 10.3390/antibiotics14080843.
3
Post-fluoroquinolone treatment molecular events and nutrient availability modulate antibiotic persistence.
bioRxiv. 2025 Jun 26:2025.06.26.661800. doi: 10.1101/2025.06.26.661800.
4
Antibiotic-persistent bacterial cells exhibiting low-level ROS are eradicated by ROS-independent membrane disruption.
mBio. 2025 Aug 13;16(8):e0119925. doi: 10.1128/mbio.01199-25. Epub 2025 Jun 30.
5
Broad-spectrum antimicrobial activity and efficacy of SK1260 against bacterial pathogens.
Front Microbiol. 2025 Apr 10;16:1553693. doi: 10.3389/fmicb.2025.1553693. eCollection 2025.
6
Cell-free synthetic biology for natural product biosynthesis and discovery.
Chem Soc Rev. 2025 May 6;54(9):4314-4352. doi: 10.1039/d4cs01198h.
7
Insights into antibiotic resistance promoted by quinolone exposure.
Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0099724. doi: 10.1128/aac.00997-24. Epub 2024 Nov 26.
8
Insights into antibacterial design: Computational modeling of eugenol derivatives targeting DNA gyrase.
Heliyon. 2024 Oct 19;10(20):e39394. doi: 10.1016/j.heliyon.2024.e39394. eCollection 2024 Oct 30.
9
Revealing antibiotic resistance's ancient roots: insights from pristine ecosystems.
Front Microbiol. 2024 Oct 9;15:1445155. doi: 10.3389/fmicb.2024.1445155. eCollection 2024.
10
Molecular mechanism of a triazole-containing inhibitor of DNA gyrase.
iScience. 2024 Sep 16;27(10):110967. doi: 10.1016/j.isci.2024.110967. eCollection 2024 Oct 18.
本文引用的文献
1
The antibacterial drugs market.
Nat Rev Drug Discov. 2007 Jan;6(1):19-20. doi: 10.1038/nrd2226.
2
Effect of anaerobic growth on quinolone lethality with Escherichia coli.
Antimicrob Agents Chemother. 2007 Jan;51(1):28-34. doi: 10.1128/AAC.00739-06. Epub 2006 Oct 16.
3
Lex marks the spot: the virulent side of SOS and a closer look at the LexA regulon.
Mol Microbiol. 2006 Dec;62(5):1228-38. doi: 10.1111/j.1365-2958.2006.05444.x. Epub 2006 Oct 17.
4
Moxifloxacin lethality against Mycobacterium tuberculosis in the presence and absence of chloramphenicol.
Antimicrob Agents Chemother. 2006 Aug;50(8):2842-4. doi: 10.1128/AAC.00250-06.
5
Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones.
Mol Microbiol. 2006 Aug;61(3):810-25. doi: 10.1111/j.1365-2958.2006.05275.x. Epub 2006 Jun 27.
6
Induction of Escherichia coli chromosomal mazEF by stressful conditions causes an irreversible loss of viability.
J Bacteriol. 2006 May;188(9):3420-3. doi: 10.1128/JB.188.9.3420-3423.2006.
7
Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Antimicrob Agents Chemother. 2006 Feb;50(2):600-6. doi: 10.1128/AAC.50.2.600-606.2006.
8
Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli.
Antimicrob Agents Chemother. 2006 Jan;50(1):362-4. doi: 10.1128/AAC.50.1.362-364.2006.
9
mazEF: a chromosomal toxin-antitoxin module that triggers programmed cell death in bacteria.
J Cell Sci. 2005 Oct 1;118(Pt 19):4327-32. doi: 10.1242/jcs.02619.
10
Organization of supercoil domains and their reorganization by transcription.
Mol Microbiol. 2005 Sep;57(6):1511-21. doi: 10.1111/j.1365-2958.2005.04796.x.
Zotero 插件